ClearPoint Neuro (CLPT) Cash from Operations Growth (3y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 4.78% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 9.30% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 20.35% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 22.35% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -48.14% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.50% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 50.11% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -14.75% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 15.83% |
| 10 | ClearPoint Neuro | 375.84 Mn | 340.24 Mn | 7.76 Mn | -11.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.94% |
| Dec 31, 2025 | -57.85% |
| Sep 30, 2025 | 6.77% |
| Jun 30, 2025 | 19.98% |
| Mar 31, 2025 | -13.07% |
| Dec 31, 2024 | 29.53% |
| Sep 30, 2024 | 28.61% |
| Jun 30, 2024 | 10.47% |
| Mar 31, 2024 | -21.69% |
| Dec 31, 2023 | 21.33% |
| Sep 30, 2023 | -9.52% |
| Jun 30, 2023 | -43.76% |
| Mar 31, 2023 | -34.57% |
| Dec 31, 2022 | -87.32% |
| Sep 30, 2022 | -58.68% |
| Jun 30, 2022 | -83.20% |
| Mar 31, 2022 | -91.33% |
| Dec 31, 2021 | -82.71% |
| Sep 30, 2021 | -50.07% |
| Jun 30, 2021 | -49.52% |
| Mar 31, 2021 | -2.82% |
| Mar 31, 2019 | 27.64% |
| Dec 31, 2018 | -26.76% |
| Sep 30, 2018 | 15.27% |
| Jun 30, 2018 | 27.49% |
| Mar 31, 2018 | 11.19% |
| Mar 31, 2016 | 10.49% |
| Dec 31, 2015 | 109.15% |
| Sep 30, 2015 | 6.40% |
| Jun 30, 2015 | -28.72% |
| Mar 31, 2015 | -14.11% |
| Dec 31, 2014 | 120.39% |
| Sep 30, 2014 | -18.01% |
| Jun 30, 2014 | 3.41% |
| Mar 31, 2014 | 4.66% |